Science Explorer Interactive view Map
Company · Pudong · China

GenomiCare (China)

genomicarebio.comROR OpenAlex
Research works
25
▲ 515% vs 2013–17
Citations
259
10.5 per fractional work
Top-10% rate
27.0%
record average 16.5%
Open access
54%
world 28%

Not ranked overall: GenomiCare (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.47× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 4.97× its world share, 0 worksImmunology and Micro…Neuroscience: 0.74× its world share, 0 worksNeuroscienceComputer Science: 0.26× its world share, 0 worksComputer ScienceMedicine: 3.23× its world share, 4 worksMedicineBusiness, Management and Accounting: 0.13× its world share, 0 worksBusiness, Management…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.5×. Every wedge is a field page.

Which keywords describe research at GenomiCare (China)?

By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, Cell-Free DNA, Cancer Genomics, Mutational Signatures, Chemotherapy, Tumor Microenvironment, Precision Medicine and Immune Checkpoint Blockade.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Targeted Therapy6▲ 106×3 topics
  2. Cell-Free DNA4▲ 202×2 topics
  3. Cancer Genomics4▲ 304×1 topic
  4. Mutational Signatures4▲ 304×1 topic
  5. Chemotherapy4▲ 21×11 topics
  6. Tumor Microenvironment3▲ 33×4 topics
  7. Precision Medicine2▲ 27×3 topics
  8. Cancer2▲ 5.4×8 topics
  9. Immune Checkpoint Blockade2▲ 141×1 topic
  10. PD-1 and PD-L12▲ 141×1 topic
  11. Cetuximab2▲ 88×2 topics
  12. Clinical Trials2▲ 11×3 topics
  13. Immunotherapy2▲ 11×5 topics
  14. Radiotherapy2▲ 18×4 topics
  15. Fluorouracil2▲ 197×1 topic
  16. Genomic Profiling2▲ 65×2 topics
  17. KRAS Mutations2▲ 197×1 topic
  18. Treatment Guidelines2▲ 29×2 topics
  19. ALK Inhibitors1▲ 104×1 topic
  20. EGFR Mutations1▲ 104×1 topic
  21. Prognostic Factors1▲ 12×6 topics
  22. Glioblastoma1▲ 82×1 topic
  23. Molecular Characterization1▲ 27×3 topics
  24. Temozolomide1▲ 82×1 topic
  25. Obesity1▲ 5.8×3 topics
  26. Mental Health1▲ 3.6×2 topics

Which research topics does GenomiCare (China) publish most on?

By volume in 2022–2025: Ferroptosis and cancer prognosis, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics and Glioma Diagnosis and Treatment.

Ferroptosis and cancer p…0Ferroptosis and cancer prognosis: 0 fractional worksCancer Immunotherapy and…0Cancer Immunotherapy and Biomarkers: 0 fractional worksCancer Genomics and Diag…0Cancer Genomics and Diagnostics: 0 fractional worksGlioma Diagnosis and Tre…0Glioma Diagnosis and Treatment: 0 fractional worksCancer-related molecular mechanisms research: 0 fractional worksColorectal Cancer Treatments and Studies: 0 fractional worksEpilepsy research and tr…0Epilepsy research and treatment: 0 fractional worksLung Cancer Diagnosis and Treatment: 0 fractional worksLymphoma Diagnosis and Treatment: 0 fractional worksImmune Cell Function and Interaction: 0 fractional works
Pulmonary and Respiratory MedicineOncologyCancer ResearchGenetics3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 0 works
  3. 3 Cancer Genomics and Diagnostics Cancer Research 0 works
  4. 4 Glioma Diagnosis and Treatment Genetics 0 works
  5. 5 Cancer-related molecular mechanisms research Cancer Research 0 works
  6. 6 Colorectal Cancer Treatments and Studies Oncology 0 works
  7. 7 Epilepsy research and treatment Psychiatry and Mental health 0 works
  8. 8 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  9. 9 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  10. 10 Immune Cell Function and Interaction Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.0%not open46.0%

World: 28% of research is openly available.

with international co-authors12.7%domestic only87.3%

World: 19% is written across borders.

How has GenomiCare (China)'s research output changed?

Output in 2018–2022 was 515% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Pudong

All research institutions in Pudong

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.